DaVita gains after upbeat quarterly profit prompts annual forecast raise

DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell.

Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings

Improvement in revenue per treatment and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the first quarter.

3 Healthcare Stocks With the Potential to Triple Your Investment by 2026

Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks.

Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?

Mitsubishi is a stock Buffett plans to own "indefinitely" and is his biggest winner year to date. Nu Holdings continues to grow by leaps and bounds in Latin America.

Is Trending Stock DaVita Inc. (DVA) a Buy Now?

Recently, Zacks.com users have been paying close attention to DaVita HealthCare (DVA). This makes it worthwhile to examine what the stock has in store.

DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors

DaVita HealthCare (DVA) closed at $127.82 in the latest trading session, marking a +1.36% move from the prior day.

DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note

The latest trading day saw DaVita HealthCare (DVA) settling at $126.11, representing a -1.2% change from its previous close.

DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call

DENVER , April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p...

Market Jitters: 2 Top Ranked Stocks for Defensive Positioning

Just this morning, the CPI data reported a notable and surprise increase in the rate of inflation. Although disinflationary pressure have been strong since early 2023, it seems those forces have re...

Here's Why You Should Add DaVita (DVA) to Your Portfolio

DaVita's (DVA) strength in its kidney care raises optimism about the stock.

Is Most-Watched Stock DaVita Inc. (DVA) Worth Betting on Now?

Zacks.com users have recently been watching DaVita HealthCare (DVA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Why the Market Dipped But DaVita HealthCare (DVA) Gained Today

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $133.73, denoting a +0.09% change from the preceding trading day.

Diagnosing the Economy Ahead of World Health Day: 6 Picks

Similar to the six vital nutrients required for good health, we have examined the six pillars that support the economy and zeroed in on stocks that have a Zacks Rank #1 (Strong Buy) or 2 (Buy) and ...

DaVita HealthCare (DVA) Is Up 1.09% in One Week: What You Should Know

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

4 Stocks Trading Near 52-Week High That Can Climb Further

Investors target stocks that have been on a bullish run lately. Stocks like HST, EAT, DVA and PPC that are seeing price strength have a high chance of carrying the momentum forward.


Related Companies

Track Institutional and Insider Activities on DVA

Follow DAVITA INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVA shares.

Notify only if

Insider Trading

Get notified when an Davita Inc. insider buys or sells DVA shares.

Notify only if

News

Receive news related to DAVITA INC.

Track Activities on DVA